Given that under pathological circumstances AID and APOBECs’ aberrant expression/activity and/or aberrant mechanisms of recruitment to target(s) and/or aberrant processing of the resulting mismatches might take place, their oncogenicity and contribution to the development and/or progression of cancer have been proposed [2, 13–23]. The gene discussed is AICDA; the disease is cancer.